Marcaine Spinal

Bupivacaine Hydrochloride in Dextrose · BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL · Injection, Solution · Subarachnoid · Hospira, Inc.

NDC 00409-1761-10 · 2 CELLO PACK in 1 CARTON / 5 AMPULE in 1 CELLO PACK / 2 mL in 1 AMPULE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built

Data sources

CMS NADAC (pharmacy acquisition, weekly)
CMS Part B ASP quarterly payment limits
CMS Maximum Fair Prices (IRA negotiated, NDC-level)
Medicare Part D Spending by Drug (data.cms.gov, name-matched)
VA FSS / Big4 federal contract prices (va.gov, twice monthly)
ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
California SB-17 WAC filings (list price, per package)

Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Medicare Part B pays (ASP+6%)$0.0110per billing unit (0.5 MG)HCPCS J0665 · Jul 1, 2026
Federal ceiling (Big4)$35.18per package of 10X2MLPfizer Inc. · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$65.69

Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 0.5 MG

$0.011

HCPCS J0665 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$440

229 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: NDA018692
TE code: AP
Approval date: May 4, 1984
Patents / exclusivity: None on file

Shortage history

In shortage now — Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)Feb 20, 2018
Other
month 103 — 5× the typical 20-month injectable shortage
In shortage now — Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)Feb 20, 2018
Demand increase for the drug
month 103 — 5× the typical 20-month injectable shortage
In shortage now — Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bupivacaine Hydrochloride in Dextrose (Injection, Solution)

Labeler	Strength	First seen	Last seen
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 3, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Marcaine Spinal — NDC 00409-1761-10," retrieved September 3, 2026, https://drugdashboards.com/drug/00409176110.

Free to cite with attribution — see how the data is put together.